A comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1) 2009 viruses.

[1]  A. Hurt,et al.  The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay. , 2010, Journal of virological methods.

[2]  L. Corey,et al.  Diagnostic accuracy of an allele-specific reverse transcriptase-PCR assay targeting the H275Y oseltamivir resistant mutation in 2009 pandemic influenza A/H1N1 virus. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[3]  D. Baltimore,et al.  Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance , 2010, Science.

[4]  P. Simmonds,et al.  The emergence of oseltamivir-resistant pandemic influenza A (H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November-December, 2009. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  Ha T. Nguyen,et al.  Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses. , 2010, Antiviral research.

[6]  P. Horby,et al.  A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. , 2010, The New England journal of medicine.

[7]  E. Tuomanen,et al.  Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. , 2010, The New England journal of medicine.

[8]  Kosa Sudhorm,et al.  Pandemic (H1N1) 2009 , 2009 .

[9]  T. Uyeki.  Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1). , 2009, The New England journal of medicine.

[10]  Guy Boivin,et al.  Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. , 2009, The New England journal of medicine.

[11]  R. Garten,et al.  Detection of Molecular Markers of Drug Resistance in 2009 Pandemic Influenza A (H1N1) Viruses by Pyrosequencing , 2009, Antimicrobial Agents and Chemotherapy.

[12]  L. Finelli,et al.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans. , 2009, The New England journal of medicine.

[13]  A. Gulland.  First cases of spread of oseltamivir resistant swine flu between patients are reported in Wales , 2009, BMJ : British Medical Journal.

[14]  A. Osterhaus,et al.  Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase , 2009, Journal of Clinical Virology.

[15]  A. Kelso,et al.  Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation , 2009, Journal of Virology.

[16]  A. Hurt,et al.  Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. , 2009, Antiviral research.

[17]  L. Brammer,et al.  Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. , 2009, JAMA.

[18]  I. Barr,et al.  Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries. , 2008, Antiviral research.

[19]  M. Zambon,et al.  Rapid Quantitation of Neuraminidase Inhibitor Drug Resistance in Influenza virus Quasispecies , 2008, Antiviral therapy.

[20]  M. Zambon,et al.  Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[21]  I. Barr,et al.  A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses. , 2004, Virus research.

[22]  I. Barr,et al.  Reassortants in recent human influenza A and B isolates from South East Asia and Oceania. , 2003, Virus research.

[23]  L. Gubareva,et al.  Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. , 2003, The New England journal of medicine.

[24]  J. Oxford,et al.  The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. , 2002, Antiviral research.

[25]  N. Cox,et al.  Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. , 1995, The Journal of infectious diseases.